Research recommendation(s) from an individual piece of guidance

Research recommendations coming out of this guidance

• Induction of remission for people with moderate ulcerative colitis: prednisolone compared with
  aminosalicylates:- What is the clinical and cost effectiveness of prednisolone compared with aminosalicylates for the induction of remission for people with moderate ulcerative colitis?
• Induction of remission for people with moderate ulcerative colitis: prednisolone compared with
  beclometasone:- What is the clinical and cost effectiveness of prednisolone plus an aminosalicylate compared with beclometasone plus an aminosalicylate for induction of remission for people with moderate ulcerative colitis?
• Induction of remission for people with subacute ulcerative colitis that is refractory to systemic corticosteroids:- What are the benefits, risks and cost effectiveness of methotrexate, ciclosporin, tacrolimus, adalimumab and infliximab compared with each other and with placebo for induction of remission for people with subacute ulcerative colitis that is refractory to systemic corticosteroids?
• Maintenance treatment for people with mild to moderate ulcerative colitis:- What is the clinical and cost effectiveness of regular maintenance treatment compared with no regular treatment (but rapid standard treatment if a relapse occurs) in specific populations with mild to moderate ulcerative colitis?
• Risk tool for predicting the likelihood of needing surgery for adults with acute severe ulcerative colitis:- To develop and validate a risk tool that predicts the likelihood of needing surgery for adults admitted to hospital with acute severe ulcerative colitis.